A comparative study of lisinopril and atenolol on low degree urinary albumin excretion, renal function and haemodynamics in uncomplicated, primary hypertension

European Journal of Clinical Pharmacology

Volumn 43, Issue 5, 1992, Pages 469-475

  Samuelsson, O ^a   Hedner, T ^b   Ljungman, S ^a   Herlitz, H ^a   Widgren, B ^a   Pennert, K ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c NONE   (Sweden)

Author keywords

ACE inhibition; adverse events; albumin excretion; Atenolol; GFR; Hypertension; lisinopril; renal function; renal haemodynamics; urinary

Indexed keywords

ALBUMIN; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ADULT; ANGINA PECTORIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; IMPOTENCE; KIDNEY FUNCTION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; URINALYSIS;

ADULT; ALBUMINURIA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; COMPARATIVE STUDY; DIPEPTIDES; DOUBLE-BLIND METHOD; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY; LISINOPRIL; MALE; MIDDLE AGE;

EID: 0026453656     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/BF02285087     Document Type: Article

References (45)

1. Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat
2. Contrasting effects of enalapril and metoprolol on proteinuria in diabetic nephropathy
3. The antihypertensive effect of lisinopril compared to atenolol in patients with mild to moderate hypertension
4. Mechanism of angiotensin II-proteinuria in the rat
5. Comparison between total and renal plasma clearance of (51CR) EDTA
6. Renal effects of converting enzyme inhibition
7. Microalbuminuria as predictor of increased mortality in elderly people
8. Albuminuria reflects widespread vascular damage. The Steno hypothens
9. Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension
10. Longterm captopril therapy at low doses reduces albumin excretion in patients with essential hypertension and no signs of renal impairment
11. Segmental effects of norepinephrine and angiotensin II on isolated renal microvessels
12. Serial micropuncture analysis of glomerular function in two models of glomerulosclerosis
13. Microalbuminuria and causal and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension
14. Urinary albumin excretion and blood pressure in the general population
15. Regulation of glomerular filtration rate and sodium excretion by angiotensin II
16. Reduction of proteinuria by angiotensin converting enzyme inhibition
17. The contribution of systemic hypertension to progression of chronic renal failure in the rat remnant kidney: effect of treatment with an angiotensin converting enzyme inhibitor or a calcium inhibitor
18. The prognostic significance of proteinuria: the Framingham study
19. Hypertension as a cardiovascular risk factor
20. Biology of disease. Biophysiology of glomerular filtration and proteinuria
21. Mesangium and glomerular disease
22. Lipids and the kidney
23. Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis
24. Blood pressure and renal function
25. The role of microalbuminuria in essential hypertension
26. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria
27. Coronary heart disease and urinary albumin excretion rate in type 2 (non-insulin-dependent) diabetic patients
28. Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy
29. Microalbuminuria products clinical proteinuria and early mortality in maturity-onset diabetes
30. Relationship of proteinuria and albuminuria to posture and urine collection period
31. Effects of converting enzyme inhibition on barrier function in diabetic glomerulopathy
32. Effect of antihypertensive treatment on kidney function in diabetic nephropathy
33. Transcapillary escape rate of albumin and plasma volume in essential hypertension
34. Increased transcapfllary escape rate of albumin and IgG in essential hypertension
35. Increased urinary albumin rate in benign essential hypertension
36. Effects of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow inpatients with essential hypertension
37. Glomerular mesangium: its function and relationship to angiotensin II
38. Short-term effect of captopril and nifedipine on microalbuminuria induced by exercise in hypertensive diabetic patients
39. Control of hypertension with the angiotensin converting enzyme inhibitor captopril reduces glomerular proteinuria
40. Experiences from hypertension trials. Impact of other risk factors
41. Proteinuria as a prognostic factor during longterm antihypertensive care
42. Microalbuminuria and vascular permeability
43. Microalbuminuria as predictor of clinical nephropathy in insulin-depent diabetes mellitus
44. Protenuria and renal function during antihypertensive treatment for essential hypertension
45. Microalbuminuria as predictor of vascular disease in non-diabetic subjects